Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lewis

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|June 1, 2005
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tabletsFred D Sheftell, Carl G H Dahlöf, Jan Lewis Brandes, et al.
Mayo Clinic Proceedings|October 14, 2006
Assessing the ability of topiramate to improve the daily activities of patients with migraineJan Lewis Brandes, David B Kudrow, John F Rothrock, et al.
Cephalalgia : an International Journal of Headache|October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraineEgilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Cephalalgia : an International Journal of Headache|August 22, 2019
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, Suzanne Klise, John H Krege, et al.
Current Medical Research and Opinion|September 28, 2011
Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidenceJohn F Rothrock, Roger K Cady, Sheena K Aurora, et al.
Journal of General Internal Medicine|May 7, 2008
In-office discussions of migraine: results from the American Migraine Communication StudyRichard B Lipton, Steven R Hahn, Roger K Cady, et al.
Cephalalgia : an International Journal of Headache|November 23, 2019
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraineJan Lewis Brandes, David Kudrow, Paul P Yeung, et al.
JAMA|February 26, 2004
Topiramate for migraine prevention: a randomized controlled trialJan Lewis Brandes, Joel R Saper, Merle Diamond, et al.
Headache|October 24, 2009
Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of useJan Lewis Brandes, Roger K Cady, Fred G Freitag, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|June 1, 2005
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tabletsFred D Sheftell, Carl G H Dahlöf, Jan Lewis Brandes, et al.
Mayo Clinic Proceedings|October 14, 2006
Assessing the ability of topiramate to improve the daily activities of patients with migraineJan Lewis Brandes, David B Kudrow, John F Rothrock, et al.
Cephalalgia : an International Journal of Headache|October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraineEgilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Cephalalgia : an International Journal of Headache|August 22, 2019
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, Suzanne Klise, John H Krege, et al.
Current Medical Research and Opinion|September 28, 2011
Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidenceJohn F Rothrock, Roger K Cady, Sheena K Aurora, et al.
Journal of General Internal Medicine|May 7, 2008
In-office discussions of migraine: results from the American Migraine Communication StudyRichard B Lipton, Steven R Hahn, Roger K Cady, et al.
Cephalalgia : an International Journal of Headache|November 23, 2019
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraineJan Lewis Brandes, David Kudrow, Paul P Yeung, et al.
JAMA|February 26, 2004
Topiramate for migraine prevention: a randomized controlled trialJan Lewis Brandes, Joel R Saper, Merle Diamond, et al.
Headache|October 24, 2009
Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of useJan Lewis Brandes, Roger K Cady, Fred G Freitag, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Pageof 4